Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is a 600% increase over the number of companies cited in the previous quarter.
Of the 25 citations issued, the most common citation was 'You did not develop an FSVP'.
Most of the companies cited were involved in the Food and Cosmetics sector. The second most common type of company cited in the time period worked in the .
Of the companies cited, six should take voluntary actions to correct their managing operations (85.7%). Additionally, one company had to take regulatory and/or administrative actions (14.3%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Bing Innovations, LLC | Devices | 10/17/2023 | Management representative |
Bing Innovations, LLC | Devices | 10/17/2023 | Quality System Procedures |
Bing Innovations, LLC | Devices | 10/17/2023 | Quality audits - Lack of or inadequate procedures |
Bing Innovations, LLC | Devices | 10/17/2023 | Training - Lack of or inadequate procedures |
Bing Innovations, LLC | Devices | 10/17/2023 | Purchasing controls, Lack of or inadequate procedures |
Bing Innovations, LLC | Devices | 10/17/2023 | Lack of or inadequate procedures |
Bing Innovations, LLC | Devices | 10/17/2023 | Lack of or inadequate complaint procedures |
Boca Fertility | Biologics | 11/01/2023 | Risk factors, clinical evidence |
Foods USA, Inc. | Food and Cosmetics | 10/06/2023 | Develop FSVP |
Fresh Start Produce Sales, Inc. | Food and Cosmetics | 10/16/2023 | Develop FSVP |
Pangea Growers Group, LLC | Food and Cosmetics | 11/14/2023 | Develop FSVP |
Products By O2, Inc. | Drugs | 10/23/2023 | Procedures not in writing, fully followed |
Products By O2, Inc. | Drugs | 10/23/2023 | Washing and toilet facilities are deficient |
Products By O2, Inc. | Drugs | 10/23/2023 | Equipment Design, Size and Location |
Products By O2, Inc. | Drugs | 10/23/2023 | Written procedures not established/followed |
Products By O2, Inc. | Drugs | 10/23/2023 | Component identification test |
Products By O2, Inc. | Drugs | 10/23/2023 | Approval and review of procedures |
Products By O2, Inc. | Drugs | 10/23/2023 | Changes to Procedures Not Reviewed, Approved |
Products By O2, Inc. | Drugs | 10/23/2023 | Control procedures to monitor and validate performance |
Products By O2, Inc. | Drugs | 10/23/2023 | Label storage access limited to authorized personnel |
Products By O2, Inc. | Drugs | 10/23/2023 | Scientifically sound laboratory controls |
Products By O2, Inc. | Drugs | 10/23/2023 | Reserve samples identified, representative, stored |
VapoCoolShot, Inc. | Devices | 10/26/2023 | Management review dates |
VapoCoolShot, Inc. | Devices | 10/26/2023 | Quality Audits - defined intervals |
VapoCoolShot, Inc. | Devices | 10/26/2023 | Training records |